[1] 中华心血管病杂志编委会血脂异常防治对策组. 血脂异常防治建议, 1997
[2] HAUSER E R, MOOSER V, CROSSMAN A D. Design of the genetics of early onset cardiovascular disease (GENECARD)study. 2003(4)
[3] 彭澍, 彭健, 龚五星. 载脂蛋白E基因多态性与早发CHD的关系及其对血脂的影响. 中华医学遗传学杂志2001(5)
[4] 陈忠, 黄峻, 朱铁兵. 早发CHD患者同胞及子女血脂与载脂蛋白E基因多态性研究. 临床心血管病杂志2002(4). doi:10.3969/j.issn.1001-1439.2002.04.003
[5] NASSAR B A, DUNN J, TITLE L M. Relation of genetic polymorphism of apolipoprotein E,angiotensin converting enzyme,apolipoprotein B100 and glycoprotein Ⅲ and early onset of coronary heart disease, 1999
[6] KUMAR P, LUTHRA K, DWIVEDI M. Apolipoprotein E gene polymorphisms in patients with premature myocardial infarction:a case-controlled study in Asian Indians in North India. 2003
[7] VIITANEN L, PIHLAJAMAKI J, MIETTINEN R. Apolipoprotein E gene promoter (-219G/T) polymorphism is associated with premature coronary heart disease. 2001(12)
[8] SYLVIE B, CYNTHIA R C, TRACEY A M N. Effect of acylglyceride content on the structure and function of reconstituted high density lipoprotein particles. 2001
[9] LILJA H E, SORO A, YLITALO K. A candidate gene studyin low HDL-cholesterol families provides evidence for the involvement of the APOA2 gene and the APOA1C3A4 gene cluster. 2002(1). doi:10.1016/S0021-9150(2)00040-0
[10] IKEWAKI K, MATSUNAGA A, HAN H. A novel two nucleotide deletion in the apolipoprotein A- Ⅰ gene,apoA- Ⅰ Shinbashi,associated with high density lipoprotein deficiency,corneal opacities,planar xanthomas,and premature coronary artery disease. 2004(1). doi:10.1016/j.atherosclerosis.2003.09.024
[11] 黄俊军. 家族性载脂蛋白B100缺陷症, 1996
[12] KALINA, CSASZAR A, CZEIZEL A E. Frequency of the R3500Q mutation of the apolipoproteinB-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary. 2001. doi:10.1016/S0021-9150(0)00648-1
[13] 张少敏, 胡应龙, 方卫华. 载脂蛋白B等位基因变异与早发CHD的关系. 中华心血管病杂志2003(2). doi:10.3969/j.issn.1007-5410.2003.02.001
[14] HONG S H, RHYNE J, ZELLER K. ABCA1 (Alabama):a novel variant associated with HDL deficiency and premature coronary artery disease. 2002(2). doi:10.1016/S0021-9150(2)00106-5
[15] CENARRO A, ARTIEDA M, CASTILLO S. A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia. 2003(3)
[16] TRIP M D, SMULDERS Y M, WEGMAN J J. Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease. 2002(7). doi:10.1161/01.CIR.0000028420.27813.C0
[17] POCATHIKORN A, GRANATH B, THIRY E. Influence of exonic polymorphisms in the gene for LDL receptor-related protein(LRP) on risk of coronary artery disease. 2003(1). doi:10.1016/S0021-9150(3)00087-X
[18] van BOCKXMEER F M, LIU Q, MAMOTTE C. Lipoprotein lipase D9N,N291S and S447X polymorphisms:their influence on premature coronary heart disease and plasma lipids. 2001(1). doi:10.1016/S0021-9150(0)00717-6
[19] 陈忠, 黄峻, 朱铁兵. 早发CHD患者脂蛋白脂酶基因多态性与血脂关系研究. 临床心血管病杂志2002(10). doi:10.3969/j.issn.1001-1439.2002.10.003
[20] SZCZEKLIK A, SANAK M, JANKOWSKI M. Mutation A1298C of methylenetetrahydrofolate reductase:risk for early coronary disease not associated with hyperhomocysteinemia, 2001(1)
[21] MAGER A, BATTLER A, BIRNBAUM Y. Plasma homocysteine,methy enetl etrahydrofolate reductase genotypes,and age at onset of symptoms of myocardial ischemia, 2002(8)
[22] RANJITH N, PEGORARO R J, ROM L. Risk factors and methylenetetrahydrofolate reductase gene polymorphisms in a young South African Indian-based population with acute myocardial infarction, 2003(3)
[23] PINTO X, VILASECA M A, GARGIA-GIRALT N. Homocysteine and the MTHFR 677C- ＞ T allele in premature coronary artery disease. Case control and family studies, 2001(1)
[24] 王小玲, 顾东风, 孙峰. 亚甲基四氢叶酸还原酶基因C667T突变与冠心病的连锁分析. 中华医学遗传学杂志2001(3)
[25] TSAI M Y, CARG U, KEY N S. Molecular and biochemical approaches in the identification of heterozygous for homocysteinuria. 1996. doi:10.1016/0021-9150(95)05748-X
[26] TSAI M Y, WELGE B G, HANSON N Q. Genetic causes of mild hyperomocysteinemia in patients with premature occlusivecoronary artery disease. 1999(1). doi:10.1016/S0021-9150(98)00271-8
[27] BERKOVICH O A, BAZHENOVA E A, VOLKOVA E A. I/D polymorphism in the angiotensin converting enzyme gene in men with myocardial infarction at young age, 2001(5)
[28] PETROVIC D, ZORC M, KANIC V. Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction. 2001(4). doi:10.1177/000331970105200403
[29] SOBSTYL J, DZIDA G, PUZNIAK A. Angiotensin-converting enzyme gene insertion/deletion polymorphism in Polish patients with myocardial infarction, 2002(2)
[30] WEISS E J, BRAY P F, TAYBACK M. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis, 1996
[31] GOLDSCHMIDT-CLERMONT P J, COLEMAN L D, PHAM Y M. Higher prevalence of GPⅢⅠ A2 polymorphism in siblings of patients with premature coronary heart disease, 1999
[32] 马会利, 陈纪林, 冯军. 年轻心肌梗死患者纤维蛋白原基因βG455 A多态性研究. 中华心血管病杂志2002(2)
[33] MIKKELSSON J, PEROLA M, WARTIOVAARA U. Plasminogen activator inhibitor- 1( PAI- 1 ) 4G/5G polymorphism,coronary thrombosis,and myocardial infarction in middle-aged Finnish men who died suddenly, 2000
[34] VIITANEN L, PIHLAJAMAKI J, HALONEN P. Association of angiotensin converting enzyme and plasminogen activator inhibitor- 1 promoter gene polymorphisms with features of the imulin resistance syndrome in patients with premature coronary heart disease. 2001(1). doi:10.1016/S0021-9150(0)00705-X
[35] DORSCH M F, BARRETT J A, LAWRANCE R A. Premature coronary artery disease shows no evidence of linkage to loci encoding for tissue inhibitors of matrix metalloproteinases. 2003(10)
[36] GRANATH B, TAYLOR R R, van BOCKXMEER F M. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. 2001(4)
[37] NASSAR B A, BEVIN L D, JOHNSTONE D E. Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease. 2001(4)
[38] WENZEL R, ERNST M, ROHDE K. DNA polymorphisms in adhesion molecude genes:a new risk factor for esrly atherosclerosis, 1996
[39] ZHENG F, CHEVALIER J A, ZHANG L Q. An HphI polymorphism in the E-selectin gene is associated with premature coronary artery disease. 2001(1). doi:10.1034/j.1399-0004.2001.590110.x
[40] TOPOL E J, McCARTHY J, GABRIEL S. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. 2001(22). doi:10.1161/hc4701.100910
[41] BOEKHOLDT S M, TRIP M D, PETERS R J. Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction, 2002(12)
[42] INBAL A, FREIM D, MODAN B. Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young mals, 1999
[43] BATALLA A, ALVAREZ R, REGUERO J R. Synergistic effect between apolipoprotien E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction, 2000 |
